Table I. Baseline risks for the different final diagnoses using the combined IOTA phase 1-3 dataset (n = 5909).

	Overall	Oncology center	Other center
Benign	68.2%	48.8%	83.7%
Malignant	31.8%	51.2%	16.3%
Borderline	6.3%	9.3%	3.8%
Stage I invasive	7.4%	10.3%	4.6%
Stage II-IV invasive	14.1%	24.3%	6.4%
Secondary metastatic	4.0%	7.3%	1.6%